Stability Convergence in Antibody Coformulations
Author:
Affiliation:
1. Department of Biochemical Engineering, UCL, WC1E 6BTLondon, U.K.
2. EPSRC Future Targeted Healthcare Manufacturing Hub, UCL, WC1E 6BTLondon, U.K.
Funder
Engineering and Physical Sciences Research Council
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c00534
Reference32 articles.
1. CD47 is a novel potent immunotherapy target in human malignancies: current studies and future promises
2. Evolving synergistic combinations of targeted immunotherapies to combat cancer
3. Combination cancer immunotherapy and new immunomodulatory targets
4. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
5. The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Stability of Protein Pharmaceuticals: Recent Advances;Pharmaceutical Research;2024-06-27
2. Crystal structures and molecular dynamics simulations of a humanised antibody fragment at acidic to basic pH;Scientific Reports;2023-09-28
3. EPR Viscometric Measurements Using a 13C-Labeled Triarylmethyl Radical in Protein-Based Biotherapeutics and Human Synovial Fluids;Applied Magnetic Resonance;2023-06-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3